How Ozempic Works—and What’s Still a Mystery
Few medications have become as popular and culturally relevant as Ozempic has, but how exactly do it and similar drugs affect ...
STAT22h
Novo’s new obesity drug shows modest results, raises concerns of psychiatric side effects
A next-generation obesity drug candidate from Novo Nordisk produced modest weight loss, along with a higher rate of some ...
Zacks.com on MSN1d
NVO Gets Positive CHMP Opinion for Wegovy's Label Update in EU
Novo Nordisk A/S NVO announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (“CHMP”) ...
The Prototype: The Scientist Betting That Worm Secretions Fix Autoimmune Diseases
Plus: The story behind the award-winning science that led to Ozempic, the next astronaut launch and why homework is good for ...
Novo Nordisk's Wegovy Gets EU Backing to Treat Obesity-Related Heart Failure
Novo Nordisk said it expects the European Medicines Agency to implement the EU label update on Wegovy to reflect reduced heart failure symptoms and improved physical function shortly. The company also ...
Research That Led to Obesity Drugs Wins Major Medical Prize
Three scientists were recognized by the Lasker Awards for their work on the GLP-1 hormone. Others were honored for work to ...
Hims & Hers To Offer Access To Compounded Diabetes And Weight Loss Drugs For Just $99/Month To Certain Professional Personnel
Hims & Hers Health will offer compounded GLP-1 weight-loss medications for as low as $99 per month to eligible U.S. military ...
Novo Nordisk: The Street Is Not Seeing The Growth Acceleration Potential
Novo Nordisk A/S's shares have stalled recently, but this looks like a natural digestion of gains from prior years. Click for ...
Achieving Weight Loss: New Study Identifies Key Factors of Success
The study concentrates on the FDA-approved injectable medications semaglutide and liraglutide. A study conducted by the ...